Organogenesis Holdings (ORGO) Inventory Average (2019 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Inventory Average of $29.0 million for Q1 2026, up 4.49% year-over-year from $27.8 million in Q1 2025, and down 16.12% quarter-over-quarter from $34.6 million in Q4 2025.
Organogenesis Holdings (ORGO) Inventory Average (2019 - 2026) Analysis & Trends
Organogenesis Holdings' Inventory Average history runs 8 years deep, the most recent figure standing at $29.0 million for Q1 2026.
- In Q1 2026, Inventory Average rose 4.49% year-over-year to $29.0 million; the TTM figure through Mar 2026 stood at $29.0 million (up 4.49% YoY), while the FY2025 annual figure was $27.9 million, up 2.52% from the prior year.
- Inventory Average for Q1 2026 stood at $29.0 million, down from $34.6 million in the prior quarter.
- The five-year high for Inventory Average was $36.3 million in Q3 2025, with the low at $23.0 million in Q2 2022.
- The 5-year median for Inventory Average is $27.0 million (2024), against an average of $27.6 million.
- The sharpest annual moves came in 2022 and 2025: Inventory Average slipped 20.5% in 2022, then jumped 34.69% in 2025.
- Organogenesis Holdings' Inventory Average stood at $24.7 million in 2022, then climbed by 13.53% to $28.1 million in 2023, then decreased by 5.17% to $26.6 million in 2024, then climbed by 29.96% to $34.6 million in 2025, then declined by 16.12% to $29.0 million in 2026.
- Business Quant data shows ORGO's Inventory Average at $29.0 million in Q1 2026, $34.6 million in Q4 2025, and $36.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 28.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.85 Mn |
| Mar 31, 2026 | 29.03 Mn |
| Dec 31, 2025 | 34.61 Mn |
| Sep 30, 2025 | 36.31 Mn |
| Jun 30, 2025 | 31.19 Mn |
| Mar 31, 2025 | 27.78 Mn |
| Dec 31, 2024 | 26.63 Mn |
| Sep 30, 2024 | 26.96 Mn |
| Jun 30, 2024 | 27.29 Mn |
| Mar 31, 2024 | 27.97 Mn |
| Dec 31, 2023 | 28.08 Mn |
| Sep 30, 2023 | 26.63 Mn |
| Jun 30, 2023 | 25.45 Mn |
| Mar 31, 2023 | 25.16 Mn |
| Dec 31, 2022 | 24.73 Mn |
| Sep 30, 2022 | 23.96 Mn |
| Jun 30, 2022 | 22.99 Mn |
| Mar 31, 2022 | 23.88 Mn |
| Dec 31, 2021 | 27.26 Mn |
| Sep 30, 2021 | 28.80 Mn |